HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyproterone acetate in advanced male breast cancer.

Abstract
Three male patients of 55, 63 and 71 years of age, with metastatic breast cancer, were treated with cyproterone acetate. Two patients showed complete remission, one lasting 21 months, another 51+ months and a third achieved partial remission lasting 9 months. These results suggest that cyproterone acetate may be useful in the treatment of advanced male breast cancer.
AuthorsM Lopez, A Barduagni
JournalCancer (Cancer) Vol. 49 Issue 1 Pg. 9-11 (Jan 01 1982) ISSN: 0008-543X [Print] United States
PMID6459156 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cyproterone Acetate
  • Cyproterone
Topics
  • Aged
  • Antineoplastic Agents
  • Breast Neoplasms (drug therapy)
  • Cyproterone (analogs & derivatives, therapeutic use)
  • Cyproterone Acetate
  • Drug Evaluation
  • Humans
  • Lung Neoplasms (drug therapy, secondary)
  • Male
  • Middle Aged
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: